Victoza Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition:   Obesity Intervention:   Drug: Liraglutide Sponsor:   Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition:   Diabete Type 2 Interventions:   Drug: Liraglutide;   Drug: Placebo Sponsors:   Biolingus;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials